Medical Faculty - University of Ljubljana Ljubljana
Ljubljana, 1000, Slovenia
Location status: Recruiting
NCT Number: NCT04693949
The purpose of this study is to evaluate the clinical outcome of resin-bonded fixed dental prostheses (RBFDPs) pretreated with nanostructured alumina coating (NAC).
The study adopts a prospective, randomized, controlled, double-blind design contrasting the use of NAC to air-borne particle abrasion (APA) (control) as a surface pretreatment method of zirconia RBFDPs used for replacing missing central or lateral incisors. The primary outcome evaluated is the retention/survival of the zirconia RBFDPs pretreated with APA and NAC.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
Ljubljana, 1000, Slovenia
Location status: Recruiting
Zirconia resin-bonded fixed dental prostheses (RBFDPs) have been regarded as a promising minimally invasive alternative for the replacement of missing central and lateral incisors, offering several advantages to orthodontic space closure or tooth replacement with implant-supported restorations. Debonding of the zirconia RBFDPs represents the main technical complication since clinically established airborne particle abrasion (APA) of an inert zirconia surface does not always provide sufficient resin-bond strength. Further, APA can also impair the mechanical properties of zirconia restoration affecting its long-term success. Nano-structured alumina coating (NAC) presents an alternative non-invasive zirconia surface pretreatment. The aim of this randomized controlled clinical trial is to study the effect of NAC coated bonding surface of zirconia RBFDPs affecting its debonding and clinical survival rate.
The study adopts a prospective, randomized, controlled, double-blind design contrasting the use of NAC to air-borne particle abrasion (APA) as a surface pretreatment method of zirconia RBFDPs. Healthy patients in need of a missing central or lateral incisor replacement are screened and rated to be eligible by two calibrated dentists. RBFDPs are randomly allocated into two groups and inserted by the same operator. The first group, where the bonding surface is pretreated with APA serves a control group. In the second group the restorations are pretreated with NAC. The participants and the operator are blinded to the group assignment in a double-blinded trial design. The primary outcome evaluated is the retention/survival of the RBFDP. Non-parametric tests and Kaplan-Meyer analysis will be used to determine differences between both study groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pretreatment of zirconia RBFDP with nanostructured alumina coating after milling of RBFDP's framework
Air-borne particle abrasion of zirconia RBFDPs prior to bonding
Time frame: From baseline through study completion, an average of 1 year
Survival rate is defined by debonding or restoration loss
Time frame: From baseline through study completion, an average of 1 year
Porcelain chipping
Time frame: From baseline through study completion, an average of 1 year
Zirconia framework fracture
Time frame: From baseline through study completion, an average of 1 year
Visual and tactile inspection of gingiva
Time frame: From baseline through study completion, an average of 1 year
Gingival sulcus depth measurement
Time frame: From baseline through study completion, an average of 1 year
Discoloration of a restoration margin
Time frame: From baseline through study completion, an average of 1 year
Caries between the tooth and restoration margin
Contact information is provided by the study sponsor or research team.
University of Ljubljana, Faculty of Medicine
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07482371
Adults, Children
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT01829724
Brain Damage, Chronic, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07717372
Acute Respiratory Tract Infection, Adults
Jakarta, Indonesia
View Trial DetailsNCT07283458
Children, Children Behavior Problem
Paris, France
View Trial Details